S-Space

Browse

Title

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sort by
In order
Results/Page
Authors/record

Showing results 121 to 140 of 629

Issue Date	Title / Author(s) / Citation	File
2015-10	Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma Lee, Kyung-Hun; Lee, Kyoung-Bun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Yi, Nam-Joon; Lee, Kwang-Woong; Suh, Kyung-Suk; Jang, Ja-June; Bang, Yung-Jue BMC Cancer, Vol.15, p. 721	view file DOI
2023	Clinical characteristics associated with adherence and persistence in patients with type 2 diabetes mellitus treated with dulaglutide 이데이비드승우	view file link
2012-12	Clinical Course of Neuroendocrine Tumors With Different Origins (the Pancreas, Gastrointestinal Tract, and Lung) Kim, Su-Jung; Kim, Jin Won; Oh, Do-Youn; Han, Sae-Won; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue American Journal of Clinical Oncology, Vol.35 No.6, pp.549-556	DOI
2015-08	Clinical grade production of Mesenchymal Stem Cells derived from Embryonic Stem Cells (ESC-MSC) having Therapy Effect to a Rat Model of Myocardial Infarction 김근천	view file
2013-12	Clinical Implications of VEGF, TGF-beta 1, and IL-1 beta in Patients with Advanced Non-small Cell Lung Cancer Kim, Ji-Won; Koh, Youngil; Kim, Dong-Wan; Ahn, Yong-Oon; Kim, Tae Min; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Cancer Research and Treatment, Vol.45 No.4, pp.325-333	DOI
2012-01	Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Kim, Yu-Jung; Han, Sae-Won; Kim, Tae Min; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Noh, Dong-Young; Heo, Dae Seog; Park, In Ae; Bang, Yung-Jue; Ha, Sung Whan Journal of Neuro-Oncology, Vol.106 No.2, pp.303-313	DOI
2022-06	Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves? Disease Kim, Min Joo; Cho, Sun Wook; Kim, Ye An; Choi, Hoon Sung; Park, Young Joo; Park, Do Joon; Cho, Bo Youn Endocrinology and Metabolism, Vol.37 No.3, pp.524-532	DOI
2011-04	Clinical Outcomes of Sorafenib Treatment in Patients With Metastatic Hepatocellular Carcinoma Who Had Been Previously Treated With Fluoropyrimidine Plus Platinum-based Chemotherapy Kim, Ji-Won; Lee, Jeong-Ok; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue American Journal of Clinical Oncology, Vol.34 No.2, pp.125-129	DOI
2006-11	Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients Han, Sae-Won; Kim, Tae-You; Lee, Kyung-Hun; Hwang, Pil Gyu; Jeon, Yoon Kyung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.54 No.2, pp.201-207	DOI
2009-07	Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Kim, Hee-Jun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Cho, Nariya; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue Breast Cancer Research and Treatment, Vol.116 No.1, pp.153-160	DOI
2013-07	Clinical Usefulness of AJCC Response Criteria for Neoadjuvant Chemotherapy in Breast Cancer Keam, Bhumsuk; Im, Seock-Ah; Lim, Yoojoo; Han, Sae-Won; Moon, Hyeong-Gon; Oh, Do-Youn; Cho, Nariya; Lee, Se-Hoon; Han, Wonshik; Moon, Woo Kyung; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young Annals of Surgical Oncology, Vol.20 No.7, pp.2242-2249	DOI
2011-05	Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer Baek, Sun Kyung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue BMC Gastroenterology, Vol.11, p. 56	DOI
2011-06	Clinicopathologic characteristics of patients with stage III/IV (M 0) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization Im, Seock-Ah; Kim, Jin Won; Kim, Jin-Soo; Kim, Min A.; Jordan, Bruce; Pickl, Marlene; Han, Sae-Won; Oh, Do-Youn; Lee, Hyuk Joon; Kim, Tae-You; Kim, Woo Ho; Yang, Han-Kwang; Bang, Yung-Jue Diagnostic Molecular Pathology, Vol.20 No.2, pp.94-100	DOI
2010-09	Clinicopathologic features and clinical outcomes of gastric cancer that initially presents with disseminated intravascular coagulation: A retrospective study Rhee, Jiyoung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Journal of Gastroenterology and Hepatology, Vol.25 No.9, pp.1537-1542	DOI
2013-02	Clusterin Enhances Cisplatin Resistance of Retinoblastoma 송현범	view file
2009-08	Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma Lee, J. O.; Lee, K. W.; Oh, D. Y.; Kim, J. H.; Im, S. A.; Kim, T. Y.; Bang, Y. J. Annals of Oncology, Vol.20 No.8, pp.1402-1407	DOI
2010-12	Combination Chemotherapy with S-1 and Platinum in Advanced Hepatocellular Carcinoma Kim, Su-Jung; Han, Sae-Won; Oh, Do-Youn; Yi, Nam-Joon; Kim, Yoon Jun; Im, Seock-Ah; Yoon, Jung-Hwan; Kang, Gyeong Hoon; Suh, Kyung Suk; Bang, Yung-Jue; Jang, Ja-Joon; Kim, Tae-You Anticancer Research, Vol.30 No.12, pp.5245-5250
2009-09	Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells Yoon, Young-Kwang; Kim, Hwang-Phill; Han, Sae-Won; Hur, Hyung-Seok; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Molecular Cancer Therapeutics, Vol.8 No.9, pp.2526-2536	DOI
2016-08	Combined cetuximab and pemetrexed therapy enhances cytotoxicity against crizotinib resistant non-small cell lung cancer cells by downregulating thymidylate synthase 김혜진	view file
2008-03	Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells Kim, Hwang-Phill; Han, Sae-Won; Kim, Sung-Hak; Im, Seock-Ah; Oh, Do-Youn; Bang, Yung-Jue; Kim, Tae-You Molecular Cancer Therapeutics, Vol.7 No.3, pp.607-615	DOI

1 5 6 7 8 9 10 11 32